No difference in brand name and generic drugs regarding thyroid dysfunction

There is no difference between brand-name and generic drug formulations of amiodarone -- taken to control arrhythmia – in the incidence of thyroid dysfunction, according to a study in CMAJ (Canadian Medical Association Journal).

Amiodarone, prescribed to control irregular heartbeats, is known for causing hypo- and hyper-thyroidism. Amiodarone is available in Canada in formulations as well as less costly generic versions. Generic formulations may be substituted if considered bioequivalent to the brand name drug. However, in some drugs there are concerns that generic formulas may be less effective or increase the number of adverse events.

occurs in one in five on amiodarone.

There is no information on the effects of brand-name versus generic versions of amiodarone on the incidence of thyroid dysfunction. Researchers from McGill University Health Centre and Jewish General Hospital, Montreal, Quebec; Western University of Health Sciences, Pomona, California; University of British Columbia, Vancouver, BC and the Institute for Clinical Evaluative Sciences in Toronto, Ontario sought to examine the incidence of thyroid dysfunction in patients taking brand name formulations of amiodarone compared with generic versions.

They looked at data on 60 220 patients aged 66 and older with atrial fibrillation taking amiodarone. Of these, 2804 (4.7%) used the brand-name formulation and 6278 (10.4%) took the generic formulation. There was no significant difference in rates of thyroid dysfunction between the two groups, measured in hospital admissions, visits to physicians for the condition or taking drugs for thyroid dysfunction.

"The incidence rate for thyroid dysfunction was estimated at 14.1 per 100 person-years, similar for both formulations," writes Dr. Louise Pilote, physician and researcher at the McGill University Health Center, with coauthors. "The incidence rates for hypothyroidism and hyperthyroidism per 100 person-years were comparable between brand-name and generic formulations, with hypothyroidism occurring more commonly than hyperthyroidism."

They caution that patients should be warned of the risks of amidarone when they begin the drug so they can recognize and report symptoms.

"We found no difference in the incidence of thyroid dysfunction between generic and brand-name formulations," conclude the authors. "The results from this study provide valuable information for both clinicians and policy makers concerning the prescription of brand name versus generic drugs."

In a related commentary, Dr. Aaron Kesselheim of Brigham and Women's Hospital in Boston states, "Decades of experience and numerous clinical studies suggest that patients and physicians can be confident in the bioequivalence of brand-name and generic drugs approved by Health Canada, the FDA or other similar regulatory authorities. In the rare circumstances where there is concern over interchangeability, such as for high-risk patients, it may be reasonable for physicians to take extra precautions, such as additional monitoring, when substitution occurs."

add to favorites email to friend print save as pdf

Related Stories

Americans turn to generic medications in 2010: report

Apr 22, 2011

(Medical Xpress) -- In a new report released by the IMS Institute for Healthcare Informatics, the results show that over 78% of the almost four billion prescriptions written in the U.S. in 2010 were for generic drugs. The ...

Myth busted: Some drugs do cost more in Canada

Sep 29, 2008

(PhysOrg.com) -- Canada may be recognized as a bargain hunters' paradise for prescription drugs, but a new U of T study suggests that many generic medications may be more expensive in Canada than in the U.S. The uninsured ...

Recommended for you

Seniors successfully withdraw from meds

Sep 19, 2014

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

Flu vaccine for expectant moms a top priority

Sep 18, 2014

Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.

Experts want restrictions on testosterone drug use (Update)

Sep 17, 2014

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

User comments